SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-22-000137
Filing Date
2022-10-18
Accepted
2022-10-18 08:41:47
Documents
15
Period of Report
2022-10-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K flks-20221018.htm   iXBRL 8-K 36710
2 EX-8.01 a101822slrxvoluntaryenroll.htm EX-8.01 14772
6 flks-20221018_g1.jpg GRAPHIC 26951
7 image_0a.jpg GRAPHIC 77186
  Complete submission text file 0001615219-22-000137.txt   369031

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20221018.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20221018_lab.xml EX-101.LAB 23984
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20221018_pre.xml EX-101.PRE 12633
9 EXTRACTED XBRL INSTANCE DOCUMENT flks-20221018_htm.xml XML 11339
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 221314979
SIC: 2834 Pharmaceutical Preparations